丹参川芎嗪注射液治疗老年脑梗死的临床价值

Clinical value on Salvia Miltiorrhiza Ligustrazine Injection in the treatment of elderly cerebral infarction

目的:观察丹参川芎嗪注射液治疗老年脑梗死的临床疗效。方法:选择120例确诊为脑梗死的老年患者,随机将其分为治疗组及对照组,每组各60例。对照组给予丹参注射液静脉滴注,治疗组静脉滴注丹参川芎嗪注射液。观察对比两组患者用药2周后的C反应蛋白变化、临床症状和体征改变、神经功能缺损评分及总有效率。结果:治疗后,两组C反应蛋白和神经功能缺损评分较治疗前均明显下降(P<0.05或P<0.01);治疗组治疗后C反应蛋白较对照组明显下降(P<0.01),神经功能缺损评分、总有效率均优于对照组(均P<0.05)。结论:丹参川芎嗪注射液用于治疗急性脑梗死疗效较好,值得临床应用。

Objective： To observe the efficacy of Salvia Miltiorrhiza Ligustrazine Injection in the treatment of elderly patients with cerebral infarction.Methods： A total of 120 elderly patients diagnosed as cerebral infarctions were randomly divided into treatment group and control group,each group had 60 cases.The control group was given Salvia Miltiorrhiza Injection with intravenous injection,the treatment group was given Salvia Miltiorrhiza Ligustrazine Injection.The C-reactive protein,clinical symptoms and signs of change,neurological function and the total effective rate of two groups were observed after treatment in 2 weeks.Results： After treatment,C-reactive protein of two groups decreased significantly than before treatment（P0.05,P0.01）.C-reactive protein of treatment group was better than that of the control group after treatment（P0.01）,the neurological function defect score and the total effective rate of treatment group were all higher than that of the control group after treatment（all P0.05）.Conclusion： Salvia Miltiorrhiza Ligustrazine Injection in the treatment of acute cerebral infarction is better,and worthy of clinical application.